GlassScriptPhysician profile
Alka G Sood
NPI 1588631071
$2,938.99
in general payments reported to CMS, 2019-2025
22 companies · $601 in 2025
The $601 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $128 · 2021: $437 · 2022: $184 · 2023: $581 · 2024: $628 · 2025: $601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,809.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $1,058.76 | 2023-2025 | Azstarys |
| Pfizer INC. | $211.86 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $200.57 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Sanofi Pasteur INC. | $197.74 | 2019-2025 | |
| Collegium Pharmaceutical, INC. | $184.29 | 2025 | Jornay Pm |
| Glaxosmithkline, LLC. | $150.01 | 2021 | |
| Genentech USA, INC. | $147.79 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $130.61 | 2019-2020 | |
| Seqirus USA INC | $118.28 | 2022-2025 | Flucelvax, Flucelvax Quadrivalent |
| Takeda Pharmaceuticals U.S.A., INC. | $100.31 | 2021-2022 | |
| Sobi, INC | $81.31 | 2019-2023 | |
| Ironshore Pharmaceuticals INC. | $77.42 | 2019-2023 | Jornay Pm |
| Kaleo, INC. | $68.67 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $66.75 | 2021-2023 | |
| Supernus Pharmaceuticals, INC. | $27.30 | 2025 | Qelbree |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $19.21 | 2025 | Ycanth |
| Tris Pharma INC | $18.35 | 2023 | Dyanavel Xr |
| Cranial Technologies, INC | $18.16 | 2025 | Doc Band |
| Shire North American Group INC | $17.19 | 2019 | |
| Adlon Therapeutics L.P. | $15.83 | 2020 | |
| Mission Pharmacal Company | $14.96 | 2019 | |
| Alexion Pharmaceuticals, INC. | $13.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alka Sood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.